Top Story
Medical AffairsJohnson & Johnson (J&J) is closing its nearly 200,000 square-foot research and development (R&D) outpost in Brisbane, California, less than 18 months after its grand opening. This decision was confirmed by a J&J spokesperson, emphasizing the company's ongoing commitment to California through its pharma and medtech [...]
Latest Stories
Featured Webinars
Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping
Thursday, May 23, 2024
Sponsor: OM1
Insights from the 2024 Salary Survey Report by HealthEconomics.com
Wednesday, May 1, 2024
Webinar Host: Scientist.com
The live session will focus on the latest salary and bonus trends for professionals in the field, including a comprehensive overview [...]
Beyond Accelerated Approvals: External Control Arms
Wednesday, April 10, 2024
Sponsor: Cardinal Health
Delphi Panels: What Are They Good For?
Tuesday, March 12, 2024
Sponsor: Partnership for Health Analytic Research (PHAR)
Handpicked Promotions & Highlights
Latest in Catalyst News powered by BioPharmCatalyst
04/24/2024 04:44 PM ET
Cyclacel Pharmaceuticals TNXP date announcement
Tonix Pharmaceuticals Holding now has three catalyst announcements on the calendar after revealing the date on which they will release trial results for Tonmya (TNX-102 SL) - (RELIEF/RESILIENT). Tonix Pharmaceuticals Holding plans to announce top-line [...]
Read More
04/24/2024 04:44 PM ET
Immutep Limited IMMP date announcement
Immutep Limited has an announcement scheduled for June 30, 2024 regarding their recent Phase 2b trial of Eftilagimod alpha (IMP321) and KEYTRUDA (pembrolizumab) - (TACTI-003). Our predictive system gives the drug a 33.7% chance of [...]
Read More
04/24/2024 04:44 PM ET
Affimed N.V. AFMD date announcement
Affimed N.V. now has four catalyst announcements on the calendar after revealing the date on which they will release trial results for AFM24-102 and TECENTRIQ (atezolizumab). Now that the Phase 1/2 trial is completed, Affimed [...]
Read MoreSearch HealthEconomics.com
Throw in a keyword, research topic, disease model or technology of interest